Lantheus Holdings Inc (FRA:0L8)
€ 88.82 3.24 (3.79%) Market Cap: 6.14 Bil Enterprise Value: 5.91 Bil PE Ratio: 15.32 PB Ratio: 5.43 GF Score: 91/100

Lantheus Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 12:30PM GMT
Release Date Price: €45
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Morning, everybody. My name is Luke Sergott, I cover life science tools here at Barclays. It's my pleasure to have Mary Anne Heino from Lantheus Holdings, which she's going to give us an update in our presentation today.

Mary Anne Heino
Lantheus Holdings, Inc. - CEO, President & Director

Thank you, Luke, and good morning, everyone. As Luke said, I'm Mary Anne Heino, I am President and Chief Executive Officer of Lantheus. I will warn you, I have a lot of material here today, so I'll move through some of it quickly, so we can get some questions if we have them.

The first thing I have to show is the safe harbor statement. So please, this is also available on our website. Please take a moment to read it there, but this says you should very much interpret what I say as my opinion and the opinion of the company and not necessarily a reason to invest, although I do think it's a great idea. So why don't we get into the presentation.

For those of you who are not aware,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot